Seattle Genetics

Micromet Unveils Another Fast Route To Market, Marks Pfizer As Lead Competitor
Seeking Alpha
Sun, 10/16/11 - 07:05 pm
Micromet
Pfizer
blinatumomab
acute lymphoblastic leukemia
leukemia
Bmab
SAR3419
Sanofi
inotuzumab
Genentech
Seattle Genetics
Top Mid- And Large-Cap Biotech Picks By Legendary Fund Managers
Seeking Alpha
Fri, 10/14/11 - 11:41 am
Alexion
Amgen
Amylin
Biogen Idec
Biomarin
Celgene
Gilead
Human Genome Sciences
Incyte
ONYX Pharmaceuticals
Seattle Genetics
Vertex
Theravance
Seattle Genetics: Weighing Bearish And Bullish Opinions
Seeking Alpha
Tue, 10/11/11 - 05:16 pm
Seattle Genetics
Immunogen
Millennium and Seattle Genetics Present Clinical Data on ADCETRIS™ (Brentuximab Vedotin) in Pediatric Patients at EMCC Annual Meeting
Yahoo/BusinessWire
Sat, 09/24/11 - 12:48 pm
Seattle Genetics
Millennium
Adcetris
Hodgkin's lymphoma
anaplastic large-cell lymphoma
Dendreon Shareholders May Yet Have The Last Laugh
Seeking Alpha
Thu, 09/22/11 - 02:26 pm
Dendreon
Provenge
prostate cancer
shareholders
Seattle Genetics
Seattle Genetics Faces Hurdles as Investors Dread Dendreon-Like Rollout
Bloomberg
Mon, 08/22/11 - 06:13 pm
Seattle Genetics
Dendreon
Provenge
Adcetris
lymphoma
Ahead of the Bell: Seattle Genetics shares jump
Yahoo/AP
Mon, 08/22/11 - 11:49 am
Seattle Genetics
FDA
Adcetris
anaplastic large-cell lymphoma
3 biotech stocks battle the ‘Dendreon Effect’ - Company’s troubles with Provenge chill fellow drug makers
Marketwatch
Fri, 08/19/11 - 09:20 am
Dendreon
Provenge
Savient
Human Genome Sciences
Vertex Pharmaceuticals
InterMune
Seattle Genetics
Biotech Calendar: 2011-12 FDA Drug Approvals
TheStreet.com
Thu, 08/11/11 - 12:37 pm
biotech
drug approvals
FDA
Eyelea
Regeneron
Dendreon
Provenge
NuPathe
Zelrix
Adcetris
Seattle Genetics
Soliris
Alexion
Dapagliflozin
AstraZeneca
Bristol-Myers Squibb
EXPAREL
Pacira
Roche
Zelboraf
Iluvien
Alimera
Bio-T-Gel
Teva Pharmaceuticals
BioSante
Zevalin
Spectrum
ruxolitinib
Incyte
Novartis
Pfizer
crizotinib
Antares
Anturol
Bydureon
Amlyin
Eli Lilly
Alkermes
AZ-004
Alexza
Corlux
Corcept Therapeutics
Affymax
Takeda
peginesatide
Levadex
MAP Pharmaceuticals
Dendreon's Blowup Spreads Across Biotech
TheStreet.com
Thu, 08/4/11 - 10:57 am
Dendreon
Provenge
InterMune
Human Genome Sciences
Seattle Genetics
Regeneron
Savient
Biotech Calendar: Key Dates for August
TheStreet.com
Tue, 08/2/11 - 12:29 pm
Alexa
Gilead Sciences
Regeneron
Dendreon
NuPathe
Provenge
Adcetris
Seattle Genetics
Eyelea
Btripla
Zelrix
AZ-004
5 Healthcare Companies With August Catalysts
Seeking Alpha
Sun, 07/31/11 - 10:20 am
Regeneron
Shire
NuPathe
Seattle Genetics
Gilead Sciences
3 Oversold, Highly Shorted Stocks Being Snapped up by Insiders
Seeking Alpha
Sat, 07/23/11 - 03:15 pm
MannKind
Seattle Genetics
5 Healthcare Stocks of Interest This Week
Seeking Alpha
Sat, 07/16/11 - 11:37 am
Transcept
Supergen
Seattle Genetics
Vical
Icagen
Seattle Genetics slides 11% on drug launch worries
Marketwatch
Fri, 07/15/11 - 02:37 pm
Seattle Genetics
Adcentris
cancer
Is Seattle Genetics the Perfect Stock?
Motley Fool
Fri, 07/15/11 - 12:59 am
Seattle Genetics
Seattle Genetics: Adcetris Panel Reconvenes (live blog)
TheStreet.com
Thu, 07/14/11 - 01:28 pm
Seattle Genetics
advisory panels
Adcetris
FDA
anaplastic large-cell lymphoma
The Big Bet on Seattle Genetics
Motley Fool
Tue, 07/12/11 - 12:13 pm
Seattle Genetics
brentuximab vedotin
Hodgkin's lymphoma
Should Biotech Investors Go Where Institutions Won't?
Investopedia
Thu, 07/7/11 - 12:04 pm
investors
biotech
Aeterna Zentaris
YM BioSciences
Ziopharm
Oncothyreon
Seattle Genetics
Exelixis
MannKind
MELA Sciences
Neoprobe
Zalicus
10 Biotech Trades for Second Half of 2011
TheStreet.com
Wed, 07/6/11 - 08:51 am
Sangamo BioSciences
BioSante
Seattle Genetics
YM BioSciences
Exelixis
Transcept
Oncothyreon
Gilead Sciences
Medivation
Neoprobe

Pages